 Moderna's candidate for the bird flu vaccine draws from mRNA technology that was used successfully during the COVID-19 response, resulting in one of the first FDA-authorized COVID-19 vaccines. The Department of Health and Human Services Secretary, Javier Becerra, said, and I quote, "...we have successfully taken lessons learned from the COVID-19 pandemic and used them to better prepare for future public health crises," end quote.